← All organizations

Highest phase reached
Phase 3
First clinical trial
Apr 22, 2019Last known activity
Feb 28, 2026
Timeline
2010s
- Jan 1, 2018
Immunovant Sciences GmbH— Founded
Drugs by trial phase (3 distinct, 19 trials)
Indications
Recent trials (19)
- NCT07286006Lead sponsorPhase 2Feb 28, 2026
- NCT07188844Lead sponsorPhase 2Aug 28, 2025
- NCT06979531Lead sponsorPhase 2Jun 30, 2025
- NCT07018323Lead sponsorPhase 2Jun 19, 2025
- NCT07039916Lead sponsorPhase 3May 27, 2025
- NCT07032662Lead sponsorPhase 2Mar 18, 2025
- NCT06980805Lead sponsorPhase 2Feb 19, 2025
- NCT06754462Lead sponsorPhase 2Jan 10, 2025
- NCT06727604Lead sponsorPhase 2Dec 31, 2024
- NCT05907668Lead sponsorPhase 2May 15, 2023
- NCT05517447Lead sponsorPhase 3Mar 31, 2023
- NCT05517421Lead sponsorPhase 3Dec 31, 2022
- NCT05581199Lead sponsorPhase 2Nov 30, 2022
- NCT05524571Lead sponsorPhase 3Oct 31, 2022
- NCT05403541Lead sponsorPhase 3Jun 27, 2022
Details
- Founded
- Basel, CH Jan 1, 2018
- Last known activity
- Feb 28, 2026